Thomas Rea

Q: What Schools Are Affiliated With Thomas Rea

Thomas Rea is affiliated with the following schools: Oberlin College, University of California, Los Angeles, University of Southern California, Okayama University

Thomas Rea's AcademicInfluence.com Rankings

Thomas Rea

Medical

#1860

World Rank

#2239

Historical Rank

#431

USA Rank

Dermatology

#39

World Rank

#53

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Why Is Thomas Rea Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas Herald Rea was an American dermatologist known for his research into treatments for leprosy. Early life Rea was born in 1929 in Three Rivers, Michigan. He graduated from Oberlin College in Ohio and the University of Michigan in Ann Arbor's medical school, where he also completed his dermatology residency.

(See a Problem?)

Thomas Rea's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions (1989) (582)
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells (2005) (433)
Comparative genomic and phylogeographic analysis of Mycobacterium leprae (2009) (353)
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses (2013) (344)
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy (2003) (339)
Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. (2004) (307)
Cytokine patterns of immunologically mediated tissue damage. (1992) (290)
Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. (1995) (281)
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. (1989) (254)
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. (1993) (239)
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. (1991) (217)
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. (1999) (207)
MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy (2011) (197)
Learning from lesions: patterns of tissue inflammation in leprosy. (1988) (192)
T-cell release of granulysin contributes to host defense in leprosy (2001) (190)
Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease (2003) (183)
Patterns of cytokine production by mycobacterium-reactive human T-cell clones (1993) (169)
Expression of Toll-Like Receptor 2 on Human Schwann Cells: a Mechanism of Nerve Damage in Leprosy (2003) (168)
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. (1994) (166)
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. (2009) (166)
IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. (1999) (159)
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. (1983) (159)
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. (2008) (147)
Tumor necrosis factor production in patients with leprosy (1992) (138)
T lymphocyte subsets in the skin lesions of patients with leprosy. (1983) (136)
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions (1986) (136)
IL-15, an immunomodulator of T cell responses in intracellular infection. (1997) (123)
Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. (1977) (121)
In situ characterization of T lymphocyte subsets in the reactional states of leprosy. (1983) (119)
NOD2 triggers an interleukin-32–dependent human dendritic cell program in leprosy (2012) (115)
Evidence for Human CD4+ T Cells in the CD1-Restricted Repertoire: Derivation of Mycobacteria-Reactive T Cells from Leprosy Lesions1 (2000) (105)
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization (1989) (103)
Suppressor T lymphocytes from lepromatous leprosy skin lesions. (1986) (100)
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. (1984) (99)
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. (1997) (97)
T Lymphocyte Subsets in Systemic Lupus Erythematosus (1983) (93)
Recognizing and managing the immunologic reactions in leprosy. (2014) (87)
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. (1985) (83)
Evidence for clonal selection of gamma/delta T cells in response to a human pathogen (1991) (81)
Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. (1984) (78)
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. (1989) (76)
Kaposi's sarcoma in homosexual men: an immunohistochemical study. (1983) (69)
Integrated pathways for neutrophil recruitment and inflammation in leprosy. (2010) (68)
T-lymphocyte subsets in lymph nodes from homosexual men. (1983) (60)
Immunological significance of Mycobacterium leprae cell walls. (1988) (60)
Erythema nodosum leprosum in a general hospital. (1975) (58)
A clinical trial of minocycline in lepromatous leprosy. (1992) (56)
Expression of adhesion molecules in leprosy lesions (1991) (55)
Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. (1993) (54)
Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy. (1986) (53)
A Role for CD40-CD40 Ligand Interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy1 (2000) (52)
Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. (1997) (51)
In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. (1986) (49)
Clinical and histologic variations among thirty patients with Lucio's phenomenon and pure and primitive diffuse lepromatosis (Latapi's lepromatosis). (2005) (49)
A Role for IL-12 Receptor Expression and Signal Transduction in Host Defense in Leprosy1 (2001) (49)
Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy. (1978) (47)
IL-7 in the cell-mediated immune response to a human pathogen. (1995) (47)
LILRA2 Activation Inhibits Dendritic Cell Differentiation and Antigen Presentation to T Cells1 (2007) (47)
S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages (2016) (46)
Gamma delta T lymphocytes in human tuberculosis. (1992) (45)
Herpes gestationis in association with a hydatidiform mole. Immunopathologic studies. (1981) (45)
Galectin-3 regulates the innate immune response of human monocytes. (2013) (44)
Lucio's phenomenon and diffuse nonnodular lepromatous leprosy. (1978) (43)
Current concepts in the immunology of leprosy. (1977) (43)
Immunoglobulin deposits in lepromatous leprosy skin. Presence of deposits in apparently uninvolved skin and occurrence of serum antiepithelial antibodies. (1975) (42)
ALTERED DISTRIBUTION OF B AND T LYMPHOCYTES IN LYMPH-NODES FROM HOMOSEXUAL MEN WITH KAPOSI'S SARCOMA (1983) (42)
Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniques. (1984) (41)
Vaccine development. On relating immunology to the Third World: some studies on leprosy. (1989) (39)
Lucio's phenomenon: a comparative histological study. (1979) (39)
Activation of FcγRI on Monocytes Triggers Differentiation into Immature Dendritic Cells That Induce Autoreactive T Cell Responses1 (2009) (38)
Immunologic responses in patients with lepromatous leprosy. (1976) (37)
Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. (1985) (36)
Histocompatibility antigens in patients with leprosy. (1976) (34)
Armadillo exposure among Mexican-born patients with lepromatous leprosy. (1987) (33)
Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. (1988) (31)
T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity. (1983) (29)
Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission. (1987) (28)
Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. (1986) (28)
Immunocompetence and prognosis in patients with gynecologic cancer. (1974) (28)
Immunohistology of tuberculous adenitis in symptomatic HIV infection. (1988) (27)
Conserved Mycobacterial Lipoglycoproteins Activate TLR2 but Also Require Glycosylation for MHC Class II-Restricted T Cell Activation1 (2008) (27)
Comparison of S-100 and OKT6 antisera in human skin. (1984) (26)
Immunoperoxidase techniques applied to dermatopathology (1983) (26)
Immunopathologic Demonstration of T Lymphocyte Subpopulations and Interleukin 2 in Graneloma Annulare (1984) (26)
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. (2016) (26)
Leprosy as Immune Reconstitution Inflammatory Syndrome in HIV-positive Persons (2007) (25)
Effect of cyclosporine A in erythema nodosum leprosum. (1986) (23)
Serum and tissue lysozyme in leprosy (1977) (22)
A comparison of stigma among patients with leprosy in rural Tanzania and urban United States: a role for public health in dermatology (2013) (21)
IL-27 suppresses antimicrobial activity in human leprosy (2015) (21)
Kaposi's Sarcoma (1983) (20)
B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy. (1998) (20)
A role for interleukin‐5 in promoting increased immunoglobulin M at the site of disease in leprosy (2010) (20)
Demonstration in situ of subsets of T‐lymphocytes in sarcoidosis (1984) (20)
Leprosy: new insight into an ancient disease. (1987) (20)
The Human CD1-Restricted T Cell Repertoire Is Limited to Cross-Reactive Antigens: Implications for Host Responses against Immunologically Related Pathogens1 (2005) (19)
Limited T-cell receptor beta-chain diversity of a T-helper cell type 1-like response to Mycobacterium leprae (1992) (18)
Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations. (1974) (17)
Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences (2007) (17)
Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. (1994) (17)
The histology of erythema nodosum leprosum. Variant forms in New Guineans and other ethnic groups. (1981) (17)
Apparently normal skin in lepromatous leprosy: histopathological findings. (1975) (16)
Selective expansion of Vδ1 + T cells from leprosy skin lesions (1992) (16)
An in situ immunohistological study of Mitsuda reactions. (1985) (15)
The 'butterfly' sign. A clue to generalized pruritus in a patient with chronic obstructive hepatobiliary disease. (1983) (15)
In situ localization of T lymphocytes in disseminated coccidioidomycosis. (1985) (15)
In situ characterization of T lymphocyte subsets in leprosy granulomas. (1982) (13)
Delayed hypersensitivity in Graves' disease. (1974) (13)
Ultrastructure of the dermal microvasculature in leprosy. (1982) (13)
Lepromin-induced suppressor cells in lepromatous leprosy. (1987) (13)
Identification of cells lining pseudovascular spaces of benign pigmented nevi. (1984) (12)
Serologic survey for markers of hepatitis B infection in dermatologists. (1985) (12)
Recent Advances in Dermatopharmacology (1978) (11)
Demonstration of a subpopulation of Ia+ T‐helper cells in mycosis fungoides and the Sézary syndrome (1983) (11)
Peripheral blood T lymphocyte subsets in leprosy. (1984) (11)
Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy. (1983) (11)
Immunopathology of leprosy granulomas (2005) (11)
Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions. (1987) (11)
Dinitrochlorobenzene responsivity in disseminated coccidioidomycosis: an inverse correlation with complement-fixing antibody titers. (1976) (11)
Immunopathology of leprosy skin lesions. (1991) (11)
Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates. (1990) (11)
Angiogenesis in cutaneous lesions of leprosy: implications for treatment. (2007) (11)
Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy. (1980) (10)
Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum. (1998) (10)
The cutaneous lesions of sarcoidosis. (1960) (10)
Regulation of human T‐cell homing receptor expression in cutaneous bacterial infection (2007) (10)
Adrenal function after topical steroid therapy (1965) (10)
CD 1 Expression by Dendritic Cells in Human Leprosy Lesions : Correlation with Effective Host Immunity 1 (1999) (9)
Immune responses in leprosy, cytokines and new archetypes for dermatology (1995) (8)
Synthesis ofNeoglycoproteins containing the 3,6-di-O-methyl-β-d-glucopyranosyl epitope and their use in serodiagnosis of leprosy (1985) (8)
A comparative study of testicular involvement in lepromatous and borderline lepromatous leprosy. (1988) (8)
Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy. (2001) (8)
Lysozyme and angiotensin converting enzyme levels in experimental mycobacterial granulomas. (1983) (8)
Elevated platelet counts and thrombocytosis in erythema nodosum leprosum. (2002) (7)
Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy. (2000) (7)
Lepromin skin testing in the classification of Hansen's disease in the United States. (1993) (7)
T-lymphocyte clones from leprosy skin lesions. (1986) (7)
Erythema nodosum leprosum in the absence of chemotherapy: a role for cell-mediated immunity. (1972) (7)
Role of granulysin in immunity to leprosy. (2000) (7)
Quantitative dinitrochlorobenzene (DNCB) responsivity and phytohemagglutinin (PHA) induced lymphocyte transformation in patients with lepromatous leprosy. (1976) (6)
Quantitative enhancement of dinitrochlorobenzene responsivity in women receiving oral contraceptives. (1979) (6)
Serum macrophage migration inhibition activity in patients with leprosy. (1982) (6)
Functional characterization of a T‐cell receptor BV6+ T‐cell clone derived from a leprosy lesion (2007) (6)
In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions. (1987) (5)
Synthesis and biological activity of new 2-substituted analogs of fluphenazine. (1976) (5)
The anatomic site of vascular injury in mouse skin exposed to ultraviolet light. (1968) (5)
γδ T Cells in Leprosy Lesions (1991) (5)
Mechanisms of immunological unresponsiveness in the spectra of leprosy and leishmaniasis. (1988) (5)
CD2 expression and function in lepromatous leprosy (1989) (5)
Reversal reaction occurring 16 years after beginning antibacterial treatment. (2004) (4)
Lesions Mycobacteria-Reactive T Cells from Leprosy CD 1-Restricted Repertoire : Derivation of T Cells in the + Evidence for Human CD 4 Porcelli and (2000) (4)
The histopathology of the spleen from a patient with lepromatous leprosy. (1980) (4)
Gamma delta T cells in leprosy lesions. (1991) (3)
In situ characterization of T lymphocyte subpopulations in leprosy in the mangabey monkey. (1986) (3)
Dermal ultrastructure in leprosy. (1984) (3)
Selective expansion of V delta 1 + T cells from leprosy skin lesions. (1992) (3)
Frequency and extent of thickening of the nucleated epidermis in leprosy lesions. (2000) (2)
Kaposi's sarcoma and autoimmune thrombocytopenia. (1984) (2)
Migration inhibition activity in leprosy sera (1980) (2)
Erythema Nodosum Leprosum-Reply (1977) (2)
Comparative Tuberculin Reactions (1974) (2)
Insitu demonstration ofTlymphocyte subsets ingranulomatous inflammation: leprosy, rhinoscleroma andsarcoidosis (1983) (2)
Clinical and Histologic Variations Among Thirty Patients with Lucio's Phenomenon and Pure and Primitive Diffuse Lepromatosis (2005) (2)
Pseudosarcomatous angioplasia: atypical presentation of pyogenic granuloma. (1983) (2)
In memoriam: John T. Crissey, MD (1925–2009) (2009) (1)
Letter: Comparative tuberculin reactions. (1974) (1)
Responses in Human Leprosy in the Generation of Type 1 Cytokine A Role for CD 40-CD 40 Ligand Interactions (2000) (1)
Molecular Approaches to Developing a Vaccine for Leprosy (1989) (1)
Leprosy in the light skin, D.L. Leiker, E. Nunzi Bologna (Eds.). Associazione Ztaliana (1984), 199, $30 (1985) (1)
Insights into Immunoregulation and Pathogenesis from a Third World Disease (1989) (1)
Latapi's lepromatosis (Lucio's leprosy) without Lucio's phenomenon in a pubertal boy. (2009) (1)
Leprosy: A Concise Text (1991) (1)
Corrigendum: Comparative genomic and phylogeographic analysis of Mycobacterium leprae (2010) (1)
Serum angiotensin-converting enzyme, transcobalamin and lysozyme in normal and lepromatous armadillos. (1979) (1)
Dinitrochlorobenzene responsivity: difference between patients with severe pulmonary coccidioidomycosis and patients with disseminated coccidioidomycosis. (1979) (1)
Teles Anti-Mycobacterial Responses Triggered Human − Type I Interferon Suppresses Type II Interferon (2013) (1)
Melanoma (1981) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF NEW 2-SUBSTITUTED ANALOGS OF FLUPHENAZINE (1976) (0)
Fcγ receptor activation triggers monocytes to differentiate into immature dendritic cells that promote autologous T cell response (2008) (0)
Dermatology-important advances in clinical medicine: carbon dioxide laser treatment in dermatology. (1983) (0)
Cross-regulatory roles of IL-10 and IL-12 in leprosy skin lesions (1993) (0)
Immunotherapy for Leprosy-Reply (1977) (0)
Dermatology-important advances in clinical medicine: naturally acquired leprosy in animals. (1983) (0)
Recent Advances in Leprosy (1997) (0)
T Differentiation and Antigen Presentation to LILRA2 Activation Inhibits Dendritic Cell (2007) (0)
Transcriptome analysis of the TLR2/1L and IFN-γ inducible gene network (2016) (0)
Fcγ receptor activation triggers monocytes to differentiate into CD1b+ immature dendritic cells (B138) (2007) (0)
OF THE ANNUAL COCCIDIOIDOMYCOSIS STUDY GROUP MEETING (2010) (0)
Serum pseudocholinesterase variants in Mexican-born patients with lepromatous leprosy. (1978) (0)
E-selectin induction by IL-1 and IFN- {gamma} in the pathogenesis of type III immune hypersensitivity (2008) (0)
Absence of an apparent influence of long-term parenteral gold therapy upon dinitrochlorobenzene sensitization and responsivity to intradermal antigens. (1980) (0)
Fc{gamma} receptor activation triggers monocytes to differentiate into CD1b+ immature dendritic cells (2007) (0)
Leprosy T Cell Responses in + Maintenance of the CD4 B7-1, But Not CD28, Is Crucial for the (1998) (0)
E‐selectin induction by IL‐1 and IFN‐ γ in the pathogenesis of type III immune hypersensitivity (2008) (0)
Continuing medical education Leprosy: New insight into an ancient disease (1987) (0)
Langerhans cells of human skin are the natural antigen‐presenting cells for CD1c antigen presentation (2008) (0)
Intracellular Infection from NK Cells and T Cells in Human IL-18 Promotes Type 1 Cytokine Production (1999) (0)
Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for antigen presentation to T cells (2008) (0)
Melanoma. Associated antigens in benign melanocytic disorders. (1981) (0)
Immunologically Related Pathogens Antigens : Implications for Host Responses Repertoire Is Limited to Cross-Reactive The Human CD 1-Restricted T Cell (2005) (0)
Clinical and Histologic Variations Among Thirty Patients with Lucio ’ s Phenomenon and Pure and Primitive Diffuse Lepromatosis ( Latapi ’ s Lepromatosis ) 1 (0)
LeprosySignal Transduction in Host Defense in A Role for IL-12 Receptor Expression and (2001) (0)
IL-27 Suppresses Antimicrobial Activity in Human (2015) (0)

This paper list is powered by the following services:

Other Resources About Thomas Rea

en.wikipedia.org

What Schools Are Affiliated With Thomas Rea?

Thomas Rea is affiliated with the following schools: